These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 6808827

  • 1. Mass screening of neuroblastoma in infancy.
    Sawada T, Todo S, Fujita K, Iino S, Imashuku S, Kusunoki T.
    Am J Dis Child; 1982 Aug; 136(8):710-2. PubMed ID: 6808827
    [Abstract] [Full Text] [Related]

  • 2. Feasibility of chemical screening of urine for neuroblastoma case finding in infancy in Quebec.
    Scriver CR, Gregory D, Bernstein M, Clow CL, Weisdorf T, Dougherty GE, Auray-Blais C, Giguère R, Lemieux B, Laberge C.
    CMAJ; 1987 May 01; 136(9):952-6. PubMed ID: 3105859
    [Abstract] [Full Text] [Related]

  • 3. Neuroblastoma. Mass screening for early detection and its prognosis.
    Sawada T, Kidowaki T, Sakamoto I, Hashida T, Matsumura T, Nakagawa M, Kusunoki T.
    Cancer; 1984 Jun 15; 53(12):2731-5. PubMed ID: 6722733
    [Abstract] [Full Text] [Related]

  • 4. Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group.
    Sawada T, Hirayama M, Nakata T, Takeda T, Takasugi N, Mori T, Maeda K, Koide R, Hanawa Y, Tsunoda A.
    Lancet; 1984 Aug 04; 2(8397):271-3. PubMed ID: 6146820
    [Abstract] [Full Text] [Related]

  • 5. VMA mass screening program of neuroblastoma for infants in Nagoya City, Japan.
    Kodama K, Nakata T, Ishii J, Mitani K, Tsunooka H, Masaoka A, Aoyama M.
    Am J Public Health; 1985 Feb 04; 75(2):173-5. PubMed ID: 3966625
    [Abstract] [Full Text] [Related]

  • 6. Effects of the mass screenings for neuroblastoma in Japan. A study of 68 cases.
    Nishi M, Miyake H, Takeda T, Takasugi N, Sato Y, Hanai J.
    Eur J Pediatr; 1988 Apr 04; 147(3):308-11. PubMed ID: 3391225
    [Abstract] [Full Text] [Related]

  • 7. Simple liquid-chromatographic measurement of vanillylmandelic acid and homovanillic acid in urine on filter paper for mass screening of neuroblastoma in infants.
    Hanai J, Kawai T, Sato Y, Takasugi N, Nishi M, Takeda T.
    Clin Chem; 1987 Nov 04; 33(11):2043-6. PubMed ID: 3677377
    [Abstract] [Full Text] [Related]

  • 8. Incidence of neuroblastoma in infancy in Japan.
    Sawada T, Kidowaki T, Sugimoto T, Kusunoki T.
    Med Pediatr Oncol; 1984 Nov 04; 12(2):101-3. PubMed ID: 6700544
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Screening for neuroblastoma in the north of England.
    Parker L, Craft AW, Dale G, Bell S, Cole M, McGill AC, Seviour JA, Smith J.
    BMJ; 1992 Nov 21; 305(6864):1260-3. PubMed ID: 1303649
    [Abstract] [Full Text] [Related]

  • 11. Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project.
    Tuchman M, Lemieux B, Auray-Blais C, Robison LL, Giguere R, McCann MT, Woods WG.
    Pediatrics; 1990 Nov 21; 86(5):765-73. PubMed ID: 2152340
    [Abstract] [Full Text] [Related]

  • 12. Number and cure rate of neuroblastoma cases detected by the mass screening program in Japan: future aspects.
    Sawada T, Sugimoto T, Tanaka T, Kawakatsu H, Ishii T, Matsumura T, Horii Y.
    Med Pediatr Oncol; 1987 Nov 21; 15(1):14-7. PubMed ID: 3561327
    [Abstract] [Full Text] [Related]

  • 13. Vanillylmandelic acid, homovanillic acid, and catecholamines in urine of infants with neuroblastoma 6- to 11-month-old.
    Nishi M, Miyake H, Takeda T, Takasugi N, Sato Y, Hanai J.
    Jpn J Clin Oncol; 1986 Dec 21; 16(4):351-5. PubMed ID: 3795531
    [Abstract] [Full Text] [Related]

  • 14. Establishment of cut off values for vanillylmandelic acid and homovanillic acid in 24-hr urine accumulation during mass screening for neuroblastoma.
    Nishi M, Miyake H, Takeda T, Takasugi N, Sato Y, Hanai J.
    Jpn J Clin Oncol; 1987 Sep 21; 17(3):221-8. PubMed ID: 3669365
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. False positive results in a neuroblastoma screening programme.
    Bell S, Parker L, Craft AW, Dale G, McGill AC, Seviour J, Cole M, Smith J.
    Med Pediatr Oncol; 1994 Sep 21; 22(3):181-6. PubMed ID: 8272007
    [Abstract] [Full Text] [Related]

  • 17. Mass screening for neuroblastoma in Japan.
    Sawada T, Sugimoto T, Kawakatsu H, Matsumura T, Matsuda Y.
    Pediatr Hematol Oncol; 1991 Sep 21; 8(2):93-109. PubMed ID: 1863547
    [Abstract] [Full Text] [Related]

  • 18. Screening for neuroblastoma: a review of the evidence.
    Chamberlain J.
    J Med Screen; 1994 Jul 21; 1(3):169-75. PubMed ID: 8790511
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Biochemical screening for neuroblastoma in infants: a feasibility study.
    Craft AW, Dale G, McGill A, Seviour J, Spence EM.
    Med Pediatr Oncol; 1989 Jul 21; 17(5):373-8. PubMed ID: 2796853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.